| pubmed-article:15653971 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15653971 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:15653971 | lifeskim:mentions | umls-concept:C0004096 | lld:lifeskim |
| pubmed-article:15653971 | lifeskim:mentions | umls-concept:C0004048 | lld:lifeskim |
| pubmed-article:15653971 | lifeskim:mentions | umls-concept:C0117996 | lld:lifeskim |
| pubmed-article:15653971 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:15653971 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:15653971 | pubmed:dateCreated | 2005-1-17 | lld:pubmed |
| pubmed-article:15653971 | pubmed:abstractText | Inhaled corticosteroids (ICSs) are an effective treatment of asthma even when administered at a low dose. Once asthma is controlled, current guidelines recommend that the dose of ICS be reduced to the lowest possible and effective dose. Although the most appropriate strategy for the stepping down has not yet been defined, quantification of sputum eosinophils and bronchial hyperresponsiveness (BHR) are indeed measures of asthma control. | lld:pubmed |
| pubmed-article:15653971 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15653971 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15653971 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:15653971 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15653971 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15653971 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15653971 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15653971 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:15653971 | pubmed:issn | 0012-3692 | lld:pubmed |
| pubmed-article:15653971 | pubmed:author | pubmed-author:TestiRenatoR | lld:pubmed |
| pubmed-article:15653971 | pubmed:author | pubmed-author:ForesiAntonio... | lld:pubmed |
| pubmed-article:15653971 | pubmed:author | pubmed-author:ChettaAlfredo... | lld:pubmed |
| pubmed-article:15653971 | pubmed:author | pubmed-author:D'IppolitoRaf... | lld:pubmed |
| pubmed-article:15653971 | pubmed:author | pubmed-author:OlivieriDario... | lld:pubmed |
| pubmed-article:15653971 | pubmed:author | pubmed-author:PelucchiAndre... | lld:pubmed |
| pubmed-article:15653971 | pubmed:author | pubmed-author:MastropasquaB... | lld:pubmed |
| pubmed-article:15653971 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15653971 | pubmed:volume | 127 | lld:pubmed |
| pubmed-article:15653971 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15653971 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15653971 | pubmed:pagination | 117-24 | lld:pubmed |
| pubmed-article:15653971 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15653971 | pubmed:meshHeading | pubmed-meshheading:15653971... | lld:pubmed |
| pubmed-article:15653971 | pubmed:meshHeading | pubmed-meshheading:15653971... | lld:pubmed |
| pubmed-article:15653971 | pubmed:meshHeading | pubmed-meshheading:15653971... | lld:pubmed |
| pubmed-article:15653971 | pubmed:meshHeading | pubmed-meshheading:15653971... | lld:pubmed |
| pubmed-article:15653971 | pubmed:meshHeading | pubmed-meshheading:15653971... | lld:pubmed |
| pubmed-article:15653971 | pubmed:meshHeading | pubmed-meshheading:15653971... | lld:pubmed |
| pubmed-article:15653971 | pubmed:meshHeading | pubmed-meshheading:15653971... | lld:pubmed |
| pubmed-article:15653971 | pubmed:meshHeading | pubmed-meshheading:15653971... | lld:pubmed |
| pubmed-article:15653971 | pubmed:meshHeading | pubmed-meshheading:15653971... | lld:pubmed |
| pubmed-article:15653971 | pubmed:meshHeading | pubmed-meshheading:15653971... | lld:pubmed |
| pubmed-article:15653971 | pubmed:meshHeading | pubmed-meshheading:15653971... | lld:pubmed |
| pubmed-article:15653971 | pubmed:meshHeading | pubmed-meshheading:15653971... | lld:pubmed |
| pubmed-article:15653971 | pubmed:meshHeading | pubmed-meshheading:15653971... | lld:pubmed |
| pubmed-article:15653971 | pubmed:meshHeading | pubmed-meshheading:15653971... | lld:pubmed |
| pubmed-article:15653971 | pubmed:meshHeading | pubmed-meshheading:15653971... | lld:pubmed |
| pubmed-article:15653971 | pubmed:meshHeading | pubmed-meshheading:15653971... | lld:pubmed |
| pubmed-article:15653971 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15653971 | pubmed:articleTitle | Step-down compared to fixed-dose treatment with inhaled fluticasone propionate in asthma. | lld:pubmed |
| pubmed-article:15653971 | pubmed:affiliation | Respiratory Pathophysiology Unit, Sesto San Giovanni Hospital, Sesto San Giovanni, Italy. antonio.foresi@aovimercate.org | lld:pubmed |
| pubmed-article:15653971 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15653971 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15653971 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:15653971 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:15653971 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
